Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Palo Alto, California
- Most recent report
- 8-K, filed Aug 17, 2026
- Incorporated
- Delaware
- Filings on record
- 825 filings
- On EDGAR
- CIK 1743881
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 29
News 8 of 104
Prospectuses and Registrations 8 of 33
- S-3ASR Automatic shelf registration Jul 24, 2026
- S-8 Registration statement for an employee plan Jul 24, 2026
- S-3ASR Automatic shelf registration May 8, 2026
- S-8 Registration statement for an employee plan Aug 5, 2025
- S-8 Registration statement for an employee plan Aug 1, 2024
- 424B5 Prospectus supplement for an offering Mar 6, 2024
- 424B5 Prospectus supplement for an offering Mar 4, 2024
- S-8 Registration statement for an employee plan Jan 5, 2024
Proxies 8 of 18
- DEFA14A Extra proxy material Apr 24, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2026
- DEFA14A Extra proxy material May 9, 2025
- DEFA14A Extra proxy material Apr 30, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2025
- PRE 14A Preliminary proxy statement Apr 16, 2025
- DEFA14A Extra proxy material Apr 25, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2024
Ownership 8 of 599
- 144 Notice of a proposed sale of restricted stock Aug 19, 2026
- 4 Insider reported a trade Aug 18, 2026
- 4 Insider reported a trade Aug 18, 2026
- 4 Insider reported a trade Aug 18, 2026
- 144 Notice of a proposed sale of restricted stock Aug 18, 2026
- SCHEDULE 13D/A Large holder reported an active stake, amended Aug 17, 2026
- 144 Notice of a proposed sale of restricted stock Aug 17, 2026
- 4 Insider reported a trade Aug 3, 2026
Other 8 of 42
Everything here comes from BridgeBio Pharma, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.